Close

Hologic (HOLX) Affirms Cigna's Decision to Cover Breast Tomosynthesis for Routine Breast Cancer Screening

Go back to Hologic (HOLX) Affirms Cigna's Decision to Cover Breast Tomosynthesis for Routine Breast Cancer Screening

Hologic Applauds Cigna as First National Insurer to Cover Breast Tomosynthesis for Routine Breast Cancer Screening

August 24, 2016 4:00 PM EDT

MARLBOROUGH, Mass., Aug. 24, 2016 /PRNewswire/ -- Hologic Inc. (Nasdaq: HOLX) applauds Cigna's decision to cover breast tomosynthesis for routine breast cancer screening.1 Effective immediately, this new policy provides Cigna subscribers insurance coverage for Hologic's Genius 3D MAMMOGRAPHY exam, the only mammogram clinically proven to detect cancer 15 months earlier than traditional 2D screenings.2

Cigna is the first national insurer to provide coverage of 3D mammograms for annual breast cancer screening for all women over age 40, and for high-risk women starting at age 25. Cigna changed its policy based on recent guidance from the National Comprehensive... More